Article
Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing.
Stem cell reports - 13 Jul 2021
Zeps Nikolajs, Lysaght Tamra, Chadwick Ruth, Erler Alexandre, Foo Roger, Giordano Simona, San Lai Poh, Schaefer G Owen, Xafis Vicki, Chew Wei Leong, Sugarman Jeremy
Abstract excerpt
Altering the human epigenome with gene-editing technology in attempt to treat a variety of diseases and conditions seems scientifically feasible. We explore some of the ethical and regulatory issues related to the clinical translation of human epigenetic editing arguing that such approaches should be considered akin to somatic therapies.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
